TABITHA
11 Nov 2020
TABITHA
ACTRN12615000232538
Treatment of Advanced Breast Cancer in the Human Epidermal Growth Factor Receptor 2 (HER2) Positive Australian Patient
BioGrid Australia Ltd
Cancer Type | Breast |
---|---|
Trial Type | Early detection, diagnosis, prognosis |
Phase | - |
Age Range | 18 years and older |
Sex | All |
Tumour Stream | Breast |
Cancer Stage | Metastatic or Widespread |
Anticipated Start Date | 2015-30-10 |
Anticipated End Date | - |
Hospital | The Queen Elizabeth Hospital |
---|---|
Clinical Trial Coordinator | Pamela Cooper |
pamela.cooper@sa.gov.au | |
Phone | 08 8222 6140 |
Principal Investigator | Dr Amanda Townsend |
Recruitment Status | Not Yet Recruiting |
Keep up to date with the latest news and breakthroughs